Sofinnova Investments, Inc. Adverum Biotechnologies, Inc. Transaction History

Sofinnova Investments, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$5.24 - $15.89 $980,189 - $2.97 Million	-187,059 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$5.1 - $11.89 $141,892 - $330,803	27,822 Added 17.47%	187,059 $2.23 Million
Q1 2019 May 15, 2019	BUY	$3.03 - $6.02 $482,488 - $958,606	159,237 New	159,237 $835,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $522M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.